Drreddys Laboratories | RDY - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bayer EUR 4.05B 647M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Drreddys Laboratories INR 26.92B 3.74B 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.44B 128M 2025-12
Pacira USD 83.88M 7.99M 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Richter Gedeon HUF 52.3B 6.68B 2025-09
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Teva Pharmaceutical Industries USD 1000M 120M 2026-03